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Recruitment of the IKK Signalosome to the p55
TNF Receptor: RIP and A20 Bind to NEMO (IKKg)
upon Receptor Stimulation
The mechanisms by which this cytokine activates NF-
kB have attracted particular attention in view of findings
indicating that, in addition to its role as a mediator of
TNF-induced activation of genes that contribute to in-
flammation and immune regulation, NF-kB also acts as
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a negative regulator of the cytotoxic function of TNFIsrael
through induction of some antiapoptotic proteins (re-
viewed in Wallach et al., 1999). Stimulation of the p55
receptor, which mediates both NF-kB and cell deathSummary
induction by TNF, incites the recruitment of a group of
signaling proteins to the receptor. Some, like the adapterThe adapter protein RIP plays a crucial role in NF-kB
proteins TRADD (Hsu et al., 1996b), RIP (Hsu et al.,activation by TNF. Here we show that triggering of the
1996a), and TRAF2 (Shu et al., 1996) as well as thep55 TNF receptor induces binding of RIP to NEMO
protein kinases NIK (Malinin et al., 1997) and MEKK1(IKKg), a component of the I-k-B-kinase (IKK) ªsig-
(Baud et al., 1999), which bind to TRAF2 and are proba-nalosomeº complex, as well as recruitment of RIP to
bly also recruited, have been suggested as participantsthe receptor together with the three major signalo-
in NF-kB activation. Others, like A20, a zinc finger proteinsome components, NEMO, IKK1 and IKK2, and some
that is itself induced by NF-kB and also binds to TRAF2,kind of covalent modification of the recruited RIP mol-
act as inhibitors of NF-kB activation (Opipari et al., 1990;ecules. It also induces binding of NEMO to the signal-
Song et al., 1996).
ing inhibitor A20, and recruitment of A20 to the recep-
Compelling evidence points to a crucial role for the
tor. Enforced expression of NEMO in cells revealed
adapter protein RIP (Stanger et al., 1995) in the activation
that NEMO can both promote and block NF-kB activa-
of NF-kB by the p55 TNF receptor. Targeted disruption
tion and dramatically augments the phosphorylation
of the RIP gene (Kelliher et al., 1998) and its mutation
of c-Jun. The findings suggest that the signaling activi- in cultured cells (Ting et al., 1996), abolish this activation.
ties of the IKK signalosome are regulated through Of the three distinct domains in RIPÐa C-terminal death
binding of NEMO to RIP and A20 within the p55 TNF domain (DD), an intermediate region, and an N-terminal
receptor complex. serine/threonine protein kinase domainÐonly the DD
and the intermediate region seem to contribute to the
Introduction activation (Hsu et al., 1996a; Ting et al., 1996). The RIP
DD mediates the recruitment of RIP to the p55 TNF
The function of NF-kB, a transcription factor controlling receptor (Hsu et al., 1996a). It binds to the DD of the
various immune defense mechanisms, is subject to intri- adapter protein TRADD, which upon stimulation binds
cate regulation through a number of different mecha- to the DD in the p55 TNF receptor (Hsu et al., 1996b).
nisms (Baeuerle and Baltimore, 1996; Ghosh et al., However, this domain alone does not suffice for NF-
1998). The most widely encountered and thoroughly kB activation. In fact, overexpression of a RIP deletion
studied is its association with inhibitory proteins of the mutant corresponding to just the DD blocks NF-kB in-
IkB family. The inhibitory effect of these proteins is allevi- duction (Hsu et al., 1996a). In contrast, expression of a
ated upon their phosphorylation in response to NF-kB- RIP mutant consisting of only its intermediate domain
inducing agents, which in turn target these proteins for suffices to activate NF-kB (Hsu et al., 1996a; Ting et
ubiquitination and proteasomal degradation. A macro- al., 1996), suggesting that this domain transmits the
molecular complex, the ªsignalosome,º plays a central signaling for downstream events in the activation.
role in this phosphorylation. This complex is comprised The only protein so far found to bind to the RIP inter-
of three major proteins: two IkB kinases, IKK1 and IKK2, mediate domain is the adapter protein TRAF2 (Hsu et
al., 1996a). Although this protein contributes to the acti-which can directly phosphorylate IkBa and b, and a
vation of NF-kB by some other receptors of the TNF/protein called NEMO (or IKKg), which lacks enzymatic
NGF family, its involvement in NF-kB activation by theactivity and whose exact role in the function of the sig-
p55 TNF receptor seems to be limited, since neither thenalosome has up to now been unknown (Chen et al.,
knockout of the TRAF2 gene (Lee et al., 1997; Yeh et1996; DiDonato et al., 1997; Mercurio et al., 1997, 1999;
al., 1997) nor of the gene for TRAF5, a related adapterRegnier et al., 1997; Woronicz et al., 1997; Zandi et al.,
protein (Nakano et al., 1999), could abolish NF-kB activa-1997; Cohen et al., 1998; Rothwarf et al., 1998; Yamaoka
tion by TNF.et al., 1998; Li et al., 1999).
In searching for additional interactions of RIP that areOne of the inducing agents employing the signalo-
required for its function, we found that the intermediatesome in NF-kB activation is tumor necrosis factor (TNF).
domain in this protein also binds to the signalosome
component NEMO and that NEMO, together with RIP² To whom correspondence should be addressed (e-mail: lvwalach@
and the two other signalosome components IKK1 andweizmann.weizmann.ac.il).
IKK2, is recruited to the p55 TNF receptor upon stimula-³ These two authors contributed equally to this work.
tion of the receptor. On further probing the function of§ Present address: Institute of Pharmacology, School of Medicine,
University of Catania, I-95025 Catania, Italy. NEMO, we found that this protein also binds A20, an
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Table 1. Binding of NEMO to RIP and A20 in Transformed Yeast
DNA Binding Domain Construct Activation Domain Construct
NEMO RIP TRAF-2 TRADD FADD A20
Full-length NEMO 1 1 2 2 2 1
Full-length RIP 1 1 1 1 1 2
RIP KD(1-285) 2 2 2 2 2 2
RIP ID(286-579) 1 2 1 2 2 2
RIP DD(580-671) 2 1 2 1 1 2
Full-length A20 1 2 1 2 2 1
A20(1-386) 1/2 2 1 2 2 2
A20(387-790) 1 2 2 2 2 1
NEMO(95-416) 1 1 2 2 2 1
NEMO(218-416) 1 2 2 2 2 2
Lamin 2 2 2 2 2 2
Yeast SFY526 cells were cotransformed with expression vectors encoding the indicated GAL4 activation domain and GAL4 binding domain
fusion proteins. Interactions between the fusion proteins were assessed by filter assays for b-galactosidase activity. The plus sign indicates
development of blue color within 2 hr of the assay, the plus/minus indicates color development in 6 hr, and the minus sign indicates no color
development within 24 hr. In further specificity assessment of the binding observed in the two-hybrid test, NEMO and A20 were found not to
bind to any of the following proteins involved in TNF signaling: the intracellular domains of the p55 and p75 TNF receptors; the adapter
proteins TRADD, MORT1/FADD, and RAIDD; the protein kinase NIK; caspase-8; caspase-1; and Bcl-2. RIP displayed binding only to TRADD,
MORT1/FADD, and RAIDD and to the intracellular domain of the p55 TNF receptor. KD, kinase domain; ID, intermediate domain; DD, death
domain.
inhibitor of NF-kB activation. We also found that modula- of NEMO suggested that both RIP and A20 bind to a
region in the middle of this protein (Table 1).tion of the cellular levels of NEMO may result in either
augmentation or inhibition of NF-kB activation. It may An assessment of the interaction of RIP, NEMO, and
A20 within mammalian cells confirmed that NEMO bindsalso dramatically enhance the phosphorylation of the
transcription factor c-Jun. to RIP as well as to A20. The bindings occurred constitu-
tively in transfected cells that overexpressed these pro-These findings indicate that regulation of the IKK sig-
nalosome by TNF involves interactions of NEMO with teins (Figures 1A±1C). In cells that did not overexpress
NEMO, however, both RIP and A20 bound to NEMO onlyRIP and A20 within the TNF receptor complex.
after TNF application or in response to overexpression
of the p55 TNF receptor (Figures 1D and 1E), whichResults
triggers signaling by this receptor (Boldin et al., 1995).
Identification of NEMO as a RIP-
and A20-Binding Protein p55 TNF-R Triggering Induces Recruitment of RIP
and of the IKK Signalosome ComponentsTo identify potential downstream components of the
p55 receptor/RIP signaling pathway, we employed the to the Receptor
RIP is recruited to the p55 TNF receptor upon stimulationyeast two-hybrid system (Fields and Song, 1989) to
screen a human B cell cDNA library (Clontech) for RIP- of the receptor (Figure 2A; Hsu et al., 1996a). Interest-
ingly, some of the recruited RIP molecules exhibit re-interacting proteins. Several specifically interacting
clones were recovered. One of these was identified as tarded migration on SDS-PAGE in a ladder-like pattern, a
change that could not be observed in the RIP moleculesa partial clone of NEMO (IKKg), a protein shown pre-
viously to be present in the signalosome and to associ- recovered from the whole cell lysate (compare upper
and lower panels in Figure 2A).ate with the IkB kinase IKK2 (Rothwarf et al., 1998; Ya-
maoka et al., 1998; Mercurio et al., 1999). Deletion In view of the observed binding of RIP to NEMO and
the reported association of NEMO with IKK2 and IKK1analysis indicated that NEMO binds to the intermediate
domain in RIP (Table 1), i.e., the region that links its DD (Rothwarf et al., 1998; Yamaoka et al., 1998; Mercurio
et al., 1999), we examined whether the last three proteinsto the kinase domain, which has been shown to mediate
NF-kB activation (Hsu et al., 1996a; Ting et al., 1996). also associate with the activated p55 TNF receptor. As
shown in Figures 2B±2D, the three proteins were indeedOn further characterizing the binding properties of
NEMO, we found that this protein does not bind to any found to coimmunoprecipitate with the p55 TNF recep-
tor from extracts of TNF-treated HeLa cells, while show-of the p55 TNF receptor±associated adapter proteins
nor to the intracellular domains of the TNF receptors ing little or no association with the receptor in the ab-
sence of TNF treatment.themselves. It does, however, bind to A20, a zinc finger
protein that exerts inhibitory effects on TNF, and has To further confirm that the signalosome components
associate with the p55 TNF receptor molecules that arealso been shown to bind to the TNF receptor-associated
protein TRAF2 (Song et al., 1996). Partial deletion analy- located on the cell surface, we immunoprecipitated the
receptor with antibodies that were applied not to thesis of A20 indicated that the latter binds to TRAF2
through its N-terminal part, a region that seems not to cell lysate but to the intact cells prior to their lysis, and
then removed the antibody molecules that did not bindbe essential for its inhibitory function (Song et al., 1996).
Its binding to NEMO, however, occurs both through its to the cell-surface receptors. As shown in Figure 2E,
the coimmunoprecipitation of IKK1 with the receptorN-terminal and, apparently more effectively, through its
C-terminal (zinc finger) region. Partial deletion analysis under these test conditions was as effective as when
IKK Signalosome Is Recruited to the TNF Receptor
303
Figure 1. Interaction of NEMO with RIP and A20 in Mammalian Cells
(A) Coimmunoprecipitation of RIP with NEMO in cotransfection assays. HEK 293T cells were transfected with expression vectors for RIP and
His epitope-tagged NEMO (5 mg each). Extracts were prepared and immunoprecipitated 24 hr later. In all figures, the antibodies applied for
immunoprecipitation (IP Abs) are indicated on top of the autoradiogram (C, control mouse antibody; His, anti-His mAb, etc.) and the antibody
applied for immunoblot analysis (WB) are indicated at the bottom.
(B and C) Coimmunoprecipitation of NEMO with A20 in cotransfection assays. HEK 293T cells were transfected with the indicated combinations
of expression vectors for FLAG-A20 and HA-NEMO or His-NEMO (5 mg each).
(D) Association of the endogenous RIP and NEMO is TNF dependent. HeLa S3 cells were treated with TNF (100 ng/ml) for 10 min (second
lane) or left untreated (first lane) before immunoprecipitation.
(E) Interaction of endogenous NEMO and transfected A20 is dependent on p55 TNF receptor triggering. HEK 293T cells were transfected with
the indicated combinations of expression vectors for the p55 TNF receptor and HA-A20. To protect cells against apoptosis induced by the
p55 TNF receptor, the receptor was transfected together with a construct expressing the p35 apoptosis inhibitor.
Samples (10 ml) of the cell lysates were applied for immunoblot analyses of the total cell extracts.
receptor molecules were immunoprecipitated from the the receptor, we assessed the phosphorylation of IkB
by the receptor-associated signalosome and comparedcell lysate and showed just as strict dependence on
TNF. it to the activity of signalosome isolated from the whole
cell lysate by immunoprecipitation of NEMO. As shownA kinetic follow-up showed that the recruitment of RIP
and IKK1 to the receptor reaches its maximal extent in Figure 3, IkB phosphorylation by the receptor-associ-
ated signalosome preparation was significantly less ef-within minutes of TNF application, and then gradually
declines, though it is still detectable 30 minutes after fective than that of the signalosome isolated from the
whole cell lysate (normalized on the basis of IKK1 levelsTNF application (Figures 2F and 2G).
To evaluate the contribution of the TNF-induced asso- in the two preparations). The signalosome components
themselves displayed a differential pattern of phosphor-ciation of RIP and NEMO to the recruitment of the sig-
nalosome components by the receptor, an antisense ylation. A protein with the molecular size of IKK1 under-
went significantly more phosphorylation in the receptor-NEMO cDNA and an N-terminal deletion mutant of RIP,
corresponding to its DD, were applied to cells. Both of associated preparation. Conversely, phosphorylation of
proteins whose sizes corresponded to those of IKK2these reagents are known to interfere with TNF-induced
NF-kB activation (Hsu et al., 1996a; Rothwarf et al., and NEMO could be discerned only in the cytoplasmic
signalosome preparation.1998). As shown in Figure 2H, expression of either con-
struct also reduced the recruitment of IKK1 to the p55
TNF receptor. A20, although Blocking the Activation of NF-kB by
TNF through Inhibition of IkB Phosphorylation,
Augments Recruitment of the SignalosomeRecruitment of the Signalosome to the p55 TNF
Receptor Seems to Be Insufficient to the p55 TNF Receptor
A20 inhibits the activation of NF-kB by TNF as well asfor Its Full Activation
To further explore the causal relationship between the by overexpression of the p55 TNF receptor or of its
adapter proteins TRAF2 or RIP, although it does notrecruitment and the activation of the signalosome by
Immunity
304
Figure 2. TNF Induces Recruitment of the IKK Signalosome to the p55 TNF Receptor Complex
(A±E) HeLa S3 cells were stimulated with TNF (100 ng/ml) for 10 min (right lane) or left untreated (left lane). Cell lysates were immunoprecipitated
with rabbit anti-p55 TNF receptor antibodies (A, B, and E) or with mouse monoclonal anti-p55 TNF receptor antibodies (C and D). Coprecipitating
RIP, IKK1, IKK2, and NEMO were detected by immunoblot analysis using the indicated antibodies. In experiment (E), the anti-p55 TNF receptor
polyclonal antibodies (1 mg/ml) were applied in a way that allowed them to interact only with the receptors expressed on the cell surface.
They were added to the tissue culture dishes before cell lysis, just after TNF application. The dishes were gently shaken for 2 hr at 48C, and
the unbound antibody was then rinsed off twice with PBS. The cells were then lysed and 40 ml of protein G-Sepharose beads were added to
the lysates to precipitate the TNF receptor complex.
(F) and (G) present the time course of the recruitment of RIP and IKK1, respectively, to the p55 TNF receptor complex. For each lane, 5 3
107 HeLa S3 cells were treated with TNF (100 ng/ml) for the indicated times. Cell lysates were immunoprecipitated with rabbit anti-p55 TNF
receptor antibody. The amounts of coprecipitating RIP and IKK1 and of RIP in aliquots of the cell lysates (10 ml) were assessed by immunoblotting
with the indicated antibodies.
(H) HeLa HtTA-1 cells (1 3 107) were transfected with expression vectors for the RIP DD (559±671) or NEMO antisense. To prevent cell death,
p35 expression vector was added to the RIP DD transfection. After 24 hr, cells were treated with TNF (100 ng/ml) for 10 min or left untreated.
Cell lysates were immunoprecipitated with rabbit anti-p55 TNF receptor antibodies, and coprecipitating IKK1 was detected by immunoblot
analysis with anti-IKK1 mAb. Immunoblotting of aliquots of the total cell extracts (10 ml) with anti-NEMO and anti-RIP or with anti-IKK1 mAbs
demonstrated specific reduction of NEMO expression in the cells expressing the NEMO antisense (data not shown).
interfere with NF-kB activation by overexpression of NIK As expected from the reported binding of A20 to
TRAF2 (Song et al., 1996), which is recruited to the p55and has only a partial inhibitory effect on its activation
by MEKK1 (Figure 4A; Song et al., 1996; Heyninck et al., TNF receptor following stimulation (Shu et al., 1996),
transfected A20 was found to associate with the p551999). The inhibition of NF-kB activation correlated with
a marked decrease in the degradation of IkB (Figure 4B). TNF receptor in cells that overexpress this receptor (Fig-
ure 4D). In view of the indicated requirement of theIndeed, the IkB-phosphorylating ability of signalosome
complexes isolated from extracts of A20-expressing NEMO-RIP interaction for activation of the signalosome,
it was of interest to determine whether the inhibition ofHeLa cells treated with TNF was substantially lower than
that of signalosome isolated from cells that did not ex- NF-kB activation by A20 reflects inhibition of the recruit-
ment of the signalosome to the receptor.press A20. Interestingly, however, the effectiveness of
self-phosphorylation of the IKKs in these signalosome As shown in Figures 4E and 4F, HEK 293T cells ex-
pressing transfected A20 did not manifest a decreasepreparations seemed not to decrease but rather to be
increased compared to cells that did not express A20 but rather a significant enhancement of IKK1 association
with the p55 TNF receptor.(Figure 4C).
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not associated with any change in the amounts of c-Jun
(Figure 5D, middle panel) and could be fully blocked
by expression of a dominant-negative mutant of SEK1
(MKK4), a MAP2K that acts upstream of JNK (data not
shown). Yet, unlike the increase in c-Jun phosphoryla-
tion that occurs in response to TNF, the increase ob-
served in NEMO-overexpressing cells was not associ-
ated with an enhanced phosphorylation of JNK at its
activation sites (Thr183/Tyr185; Karin et al., 1997; Figure
5D, lower panel). Similar modulation of NF-kB function
and c-Jun phosphorylation by NEMO could also be ob-
served in HeLa cells (data not shown).
Discussion
The choice of the term ªsignalosomeº (signaling organ-
elle) for the IkB phosphorylating complex implies that it
was conceived as a distinct structural and functional
entity. Up to now, in most fractionation studies aimed
at characterizing the IkB phosphorylating kinases, these
proteins have indeed appeared to be assembled into
a distinct and highly stable macromolecular complex,Figure 3. Kinase Activities of p55 TNF Receptor-Recruited Signalo-
some Compared with Those of Cytoplasmic IKK Signalosome containing about equal amounts of three unique compo-
HeLa S3 cells (5 3 107) were treated with TNF (20 ng/ml) for 10 min nents: IKK1, IKK2, and NEMO (DiDonato et al., 1997;
(second and fourth lanes) or left untreated (first and third lanes). Mercurio et al., 1997, 1999; Zandi et al., 1997; Rothwarf
The IKK signalosome was immunoprecipitated with anti-p55 TNF et al., 1998). Notably, however, the approaches taken
receptor (first and second lanes) or anti-NEMO (third and fourth
in those studies were biased toward the detection oflanes) polyclonal antibodies, and the associated kinase activities
components that are most prevalent and that bind mostwere determined with GST-IkBa (1±54) as a substrate. The amounts
avidly to each other. Use of high urea washes, for exam-of IKK1 in the two immune complexes were assessed by immu-
noblotting with anti-IKK1 mAb (bottom panel). ple, may well have eliminated some loosely bound yet
functionally important components (Mercurio et al.,
1997, 1999; Rothwarf et al., 1998). The findings of theA Mild Increase in the Cellular Levels of NEMO
present study indicate that, apart from the three ªcoreºPotentiates NF-kB Activation, whereas
components already identified, the IkB phosphorylatinga Greater Increase Interferes with
kinases may at times associate with some other cellularNF-kB Activation and Augments
proteins, which modulate their function. Specifically, inc-Jun Phosphorylation
cells treated by TNF, a subpopulation of the IkB phos-Assessment of the effect of enforced expression of
phorylating complexes is shown to become an integralNEMO in HEK 293T cells revealed marked inhibition of
part of the p55 TNF receptor signaling complex. NEMO,NF-kB activation in cells transfected with large amounts
a major component of the core signalosome complexof a NEMO-expressing cDNA construct (Li et al., 1999),
whose function has until now remained elusive, is shownwhereas transfection of low amounts of this construct
here to link the IkB kinases (IKKs) to components of theresulted in significant potentiation of NF-kB activation
p55 receptor complex. Being based on assessment ofas well as in increased basal activity of this transcription
interactions of signaling molecules in their normal cellu-factor (Figure 5A and inset). The inhibition of NF-kB
lar amounts, the present data provide a more reliableactivation at high cellular concentrations of NEMO could
notion of the signaling events than that obtained upbe shown to reflect suppression of IkB degradation (Fig-
to now through overexpression of these proteins. Weure 5B). Moreover, consistent with the proposed role of
cannot yet draw any definite conclusions as to the func-the NEMO-RIP association in the transmission of signal-
tional implications of the observed interactions. How-ing, the inhibition of NF-kB activation by NEMO overex-
ever, the findings are consistent with the idea that thepression was associated with decreased recruitment of
binding of NEMO to components of the receptor com-the signalosome to the receptor (Figure 5C).
plex constitutes an early though not necessarily suffi-Interestingly, high cellular NEMO was also associated
cient step in the activation of the signalosome.with a marked increase in phosphorylation of c-Jun at
Two novel interactions of NEMO were revealed in thisthe same sites as those found to be phosphorylated in
study. NEMO was found to bind to RIP, an adapterresponse to TNF (Ser63/Ser73) (Karin et al., 1997). Notably,
protein crucial for NF-kB activation by the p55 TNF re-the SDS-PAGE migration patterns of the phosphorylated
ceptor (Ting et al., 1996; Kelliher et al., 1998; also seec-Jun in NEMO-overexpressing cells differed somewhat
Li et al., 1999), as well as to A20, a protein with inhibitoryfrom those in cells treated by TNF, suggesting that,
effects on several TNF functions (Opipari et al., 1990;along with the shared effects of TNF and NEMO on
Jaattela et al., 1996). The binding of NEMO to each ofphosphorylation of Ser63 and Ser73, they also induced
these proteins could be monitored at high fidelity inadditional phosphorylation(s) of c-Jun, at specific sites.
the yeast two-hybrid test. Within the mammalian cell,The effect of NEMO on c-Jun phosphorylation was syn-
ergistic with that of TNF (Figure 5D, upper panel). It was however, the binding was stimulus dependent, being
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Figure 4. A20 Inhibits NF-kB Activation Induced by the p55 TNF Receptor, RIP, TRAF2, or MEKK1 and the Kinase Activity of the IkB Kinase
Complex but Enhances the Recruitment of IKK1 to the Receptor
(A) Effect of A20 on NF-kB dependent reporter gene activity induced by transfection of HEK 293T cells with the p55 TNF receptor, RIP, TRAF2,
NIK, or MEKK1.
(B) Effect of A20 on IkB degradation in response to TNF. 293T cells (2 3 105) were transfected in 6 cm dishes with pcHA-A20 or with empty
vector. After 24 hr, half of the samples were treated with 100 ng/ml TNF for 20 min as indicated. Cells were lysed on the dishes in SDS sample
buffer, and one-tenth of each sample was subjected to conventional SDS-PAGE followed by electrotransfer and Western blotting with anti-
IkB antiserum.
(C) Effect of A20 on kinase activity of the IKK complex. HeLa HtTA-1 cells (1 3 107) were transfected with pcDNA3 (first and second lanes)
or with pcHA-A20 (third lane). After 24 hr, the cells were stimulated with TNF (20 ng/ml) for 10 min (second and third lanes) or left untreated
(first lane). The IkB kinase complexes were isolated by immunoprecipitation with 1 mg of anti-NEMO polyclonal antibodies, and the associated
kinase activities were determined using GST-IkBa (1±54) as a substrate. The amounts of IKK1 in the immunoprecipitates were determined by
immunoblotting with anti-IKK1 mAb (bottom panel).
(D) A20 associates with overexpressed p55 TNF receptor. HEK 293T cells (1 3 107) were transfected with the indicated combinations of
expression vectors for the p55 TNF receptor and with pcHA-A20. p35 expression vector was added to the p55 TNF receptor transfections.
Cell lysates were prepared 24 hr later and subjected to immunoprecipitation and immunoblot analysis using the indicated antibodies.
(E and F) A20 expression augments the recruitment of IKK1 to the p55 TNF receptor. HEK 293T cells (1 3 107) were transfected with the
indicated plasmids. Cell lysates were immunoprecipitated with rabbit anti-p55 TNF receptor antibody. Coprecipitating endogenous RIP and
IKK1 were detected by immunoblot analysis with anti-RIP mAb (E) and anti-IKK1 mAb (F).
Aliquots of total cell extracts (10 ml) were immunoblotted with anti-HA (D), anti-RIP (E), or anti-IKK1 (F) mAbs.
detectable only after application of TNF to the cell or occurs through its binding not only to NEMO but also
to TRAF2 (Song et al., 1996). It may thus assist theupon overexpression of the p55 receptor (which results
in receptor triggering, Boldin et al., 1995). RIP is re- anchorage of NEMO and its associated proteins to the
receptor complex. Cells expressing A20 indeed dis-cruited to the p55 TNF receptor upon its triggering (Hsu
et al., 1996a) and so are NEMO and the two IKKs associ- played enhanced recruitment of the IKK complex to the
receptor (Figure 4F; see Figure 6 for a diagrammaticated with it. Our data indicate that A20 also associates
with the p55 TNF receptor. This association probably representation of the proposed protein interactions).
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Figure 5. Modulation of NF-kB Activation
and c-Jun Phosphorylation by Variation of the
Cellular Amounts of NEMO
(A) Effects of NEMO on NF-kB-dependent re-
porter gene activity induced by transfection
of HEK 293T cells with TRAF2 or NIK or their
treatment with TNF and on its basal level
(inset).
(B) Effect of high cellular amounts of NEMO
on IkB degradation in response to TNF. 293T
cells (2 3 105) were transfected in 6 cm dishes
with a NEMO expression plasmid or with an
empty vector. After 24 hr, half of the samples
were treated with 100 ng/ml TNF for 20 min.
The cells were lysed on the dishes in SDS
sample buffer, and one-tenth of each sample
was subjected to conventional SDS-PAGE
followed by electrotransfer and Western blot-
ting with anti-IkB antiserum.
(C) Effect of high cellular amounts of NEMO
(25 mg DNA/plate) on recruitment of the sig-
nalosome to the p55 TNF receptor.
(D) NEMO induces site-specific hyperphos-
phorylation of c-Jun without affecting the cel-
lular amounts of c-Jun or the extent of JNK
phosphorylation. The immunoblots prepared
as described in (B) were probed with the indi-
cated antisera. Results similar to those ob-
served with the anti-phospho Ser63 antibody
were obtained when the blots were probed
with anti-phospho Ser73 antibody. Marked po-
tentiation of the effect of NEMO on c-Jun
phosphorylation was similarly observed in
cells that, together with NEMO, overex-
pressed the p55 TNF receptor, the p75 TNF
receptor, TRADD, RIP, TRAF2, or NIK.
Recruitment of the IKK complex to the receptor occurs of rapid covalent modification, which is restricted to
those RIP molecules that have associated with the re-soon after TNF application. It precedes receptor uptake
(Figure 2E) and reaches almost its maximal extent within ceptor. This modification of RIP is reminiscent of a modi-
fication of IRAK, a serine threonine kinase that seems2 min of TNF application. It therefore seems reasonable
to assume that this recruitment constitutes an early to play a role similar to that of RIP in the IL1-induced
NF-kB activation cascade; namely, it links the receptorevent in the activation of the IKKs by the receptor. This
notion is consistent with the knowledge that RIP, the reversibly to molecules that act downstream in the sig-
naling pathway (Cao et al., 1996). In the case of IRAK,molecule responsible for the recruitment, is required for
NF-kB activation by the p55 receptor (Ting et al., 1996; these induced covalent changes could be shown to cor-
respond to ubiquitination of the protein, which leads toKelliher et al., 1998). It is also consistent with the evi-
dence that the region in RIP that is involved in the recruit- its proteasomal degradation (Yamin and Miller, 1997; Li
et al., 1999). The ªladderº-like appearance of the modi-ment (the intermediate domain) is the region known to
be crucial for NF-kB activation (Hsu et al., 1996a; Ting fied RIP molecule, which is characteristic of ubiquiti-
nated proteins, suggests that it is subject to the sameet al., 1996). However, the phosphorylation of IkB by
the kinases found in the receptor complex after TNF kind of modulation.
While the binding of RIP to NEMO may initiate thestimulation is much less effective than the phosphoryla-
tion observed with the kinase complex recovered from activation of the IKK complex by TNF, the binding of
A20 to NEMO is likely to contribute to the inhibition ofthe whole cell lysate (Figure 3). Moreover, in cells that
express A20, activation of the IKKs is blocked, in spite NF-kB by A20. The direct association of A20 with a core
component of the IKK complex is consistent with theof their recruitment to the receptor. It seems likely that
the recruitment does not suffice for full activation and ability of this protein to suppress the activation of NF-
kB by at least two different cytokines, TNF and IL1 (Jaat-that there is a need for some further modulation of the
signalosome after its release from the receptor (Fig- tela et al., 1996), which employ distinct signaling path-
ways. The binding of A20 to TRAF2, an adapter proteinure 6).
A process in which the IKK complex is repeatedly found in the signaling complex induced by TNF but not
in that induced by IL1, may specifically contribute to therecruited and then released from the p55 receptor re-
quires dynamic modulation of proteins that are involved inhibitory effect of A20 on TNF signaling. It is not crucial,
however, since an A20 mutant that is incapable of TRAF2in the recruitment. It was therefore particularly interest-
ing to find that RIP, the protein through which this re- binding can still block NF-kB activation by TNF (Song
et al., 1996). It is likely that A20 affects the function ofcruitment occurs, appears to be subject to some kind
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Figure 6. Diagrammatic Representation of the Protein Interactions Suggested to Take Part in the Recruitment of the Signalosome to the p55
TNF Receptor
the TNF receptor by more than one mechanism. Thus, affect IKK function. There are, in principle, two ways in
which such linkage may result in functional modulation.while in the present study we observed inhibition of IkB
phosphorylation in response to this protein, in another The mere translocation of the signalosome complex to
the vicinity of other proteins may allow them to modulatestudy it was shown that A20 can also inhibit the function
of NF-kB at a step subsequent to IkB degradation (Hey- IKK function. Its recruitment to the receptor may bring
the IKKs into close proximity with kinases, such as NIKninck et al., 1999). The mechanisms for these effects
remain to be clarified. Two observations in the present or MEKK1, which seem to associate with the receptor
and have the capacity to phosphorylate and thus acti-study provide conflicting clues to the mechanism(s) by
which A20 may inhibit IkB phosphorylation: (1) the inhibi- vate the IKKs (Lee et al., 1997; Ling et al., 1998). Likewise,
the physical association of A20 and the complex maytory effect of A20 on NF-kB activation could be over-
come by overexpressing NIK (also see Heyninck et al., allow proteins associated with A20 (De Valck et al., 1999;
Heyninck et al., 1999) to exert inhibitory effects on IKK1999) and to some extent also by MEKK1, raising the
possibility that A20 restricts the accessibility of the IKKs function.
Alternatively, NEMO may act as a transduction ele-to these IKK-activating kinases; (2) while inhibiting the
phosphorylation of IkB, A20 seems to augment IKK ment. Its binding to regulatory proteins may induce con-
formational changes in NEMO, which in turn transmitphosphorylation (Figure 4C), a process that may result
in inhibition of these enzymes (Delhase et al., 1999). inhibitory or stimulatory effects to its associated IKKs.
A rather surprising finding was the marked site-spe-Previous studies have indicated that NEMO plays an
important role in the regulation of IKK function but give cific (Ser63/Ser73) phosphorylation of c-Jun in cells over-
expressing NEMO. The effect of NEMO was synergisticno clue as to the mechanisms by which this molecule
acts (Yamaoka et al., 1998; Rothwarf et al., 1998; Li with that of TNF and occurred without any increase in
the phosphorylation of JNK at its activation sites (Thr183/et al., 1999; Mercurio et al., 1999). The present study
suggests that NEMO acts to link the IKKs to regulatory Tyr185). It thus appears to involve a mechanism distinct
from the one thought to account for the effect of TNFmolecules and does so in a way that allows them to
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in a two-hybrid screen of a human B cell cDNA library (Clontech) inon c-Jun phosphorylation. It may perhaps occur through
Saccharomyces cerevisiae HF7c. The isolation of positive clonesactivation of JNK by a mechanism other than its phos-
and subsequent two-hybrid interaction analyses were performedphorylation, or by activation of another as yet unknown
according to the manufacturer's instructions (Matchmaker Two-
Jun kinase, or by inhibition of a Jun phosphatase. Al- Hybrid System Protocol, Clontech). The binding properties of NEMO
though it is difficult to place this unexpected overex- and A20 as well as of the other examined proteins were assessed
in the yeast SFY526 reporter strain (Clontech) using the pGBT9pression effect in the context of the normal functioning
GAL4-DBD and pGAD GH GAL4-AD vectors. Deletion constructsof the signalosome, its existence indicates that NF-kB
for two-hybrid mapping were made by PCR.activation is not the sole signaling role of this complex.
A role of the signalosome in controlling c-Jun phosphor-
Reporter Gene Assaysylation was also indicated in a previous study in which
HEK 293T cells (2 3 105 cells/well) were seeded into 35 mm plates.NIK, a protein kinase that seems to play an important
On the following day, cells were transfected by the calcium phos-
role in the activation of the signalosome, was shown phate precipitation method (Sambrook et al., 1989). Each dish was
to have the capacity to activate AP1, a transcription transfected with 1 mg HIV LTR-luciferase, 1 mg pSV-b-galactosidase,
1 mg expression vector for the tested protein and, when indicated,complex containing c-Jun, by a mechanism that seems
2 mg HA-A20 expression vector (pcHA-A20). The amount of trans-to be independent of enhanced Jun kinase activity (Na-
fected DNA was kept constant (5 mg/well) by supplementation withtoli et al., 1997).
pcDNA3 ªemptyº vector. Twenty-four hours after transfection, theWhile the function of RIP, to which NEMO was found
cells were treated, whenever indicated, for 4 hr with TNF (100 ng/
to bind, is most probably restricted to the signaling activ- ml), then rinsed twice with phosphate-buffered saline (PBS) and
ity of the TNF receptors, the function of NEMO itself is harvested. Reporter gene activity was determined with the luciferase
assay system (Promega, Madison, WI). b-galactosidase activity wascertainly not restricted to signaling induction by TNF.
measured to normalize transfection efficiencies.Rather, it acts as a general regulator of signalosome
function (Yamaoka et al., 1998). It thus seems possible
Immunoprecipitations and Immunoblottingthat, besides binding RIP, NEMO has the ability to inter-
The choice of cell lines in these experiments was defined by theact with components of various other signaling path-
following considerations. To assess the interaction of proteins ex-ways, in each case imposing translocation of the core
pressed by transfected constructs, we used HEK 293T cells, which
signalosome to another signaling complex and transmit- are highly transfectable and express the transfected constructs at
ting the regulatory effects of these different complexes very high levels. The HEK 293T cells, however, express very little
p55 TNF receptor. The interactions of endogenous proteins andon its functions.
their recruitment to the p55 TNF receptor were therefore assessed
using HeLa cells. In experiments aimed at assessing the effects of
Experimental Procedures
transfected proteins on the endogenous proteins, we used the
HtTA-1 clone of HeLa cells, which is effectively transfectable (.50%
Cells and Materials
of the cells), or the HEK 293T cells. In other experiments we preferred
HeLa S3, the HeLa HtTA-1 clone (Gossen and Bujard, 1992), and
the HeLa S3 variant, since for some reason the background of pro-
human embryonic kidney (HEK) 293T cells were grown in Dulbecco's
teins nonspecifically recovered in the immunoprecipitation proce-
modified Eagle's minimal essential medium supplemented with 10%
dure was particularly low with lysates of these specific cells. In the
fetal calf serum, 100 U/ml penicillin, and 100 mg/ml streptomycin.
absence of highly sensitive antibodies against A20, we could detect
The anti-FLAG epitope monoclonal antibody (mAb) M2 and the anti-
it only by transfection of constructs for A20 fused with FLAG or HA
His epitope mAb were purchased from Sigma (St. Louis, MO). The
tag.
anti-HA epitope mAb 12CA5 was from Boehringer Mannheim. The
For coimmunoprecipitation of endogenous proteins, HeLa S3 cells
anti-RIP and anti-IKKa mAbs were from PharMingen (San Diego,
(0.5±2 3 108) were rinsed in warm PBS and incubated for 5 or 10
CA). Rabbit anti-NEMO and anti-HA polyclonal antibodies were from
min in the presence or absence of TNF (100 ng/ml). Cells were lysed
Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit anti-IKK2 anti-
for 45 min at 48C in 1 ml lysis buffer (20 mM Tris-HCl [pH 7.5], 150
body was a gift from Dr. A. Manning, Signal Pharmaceuticals (San
mM NaCl, 1% Triton X-100, 1 mM EDTA, 30 mM NaF, 2 mM sodium
Diego, CA). The rabbit antiserum and mAbs (clones number 34 and
pyrophosphate, 13 protease inhibitor cocktail (Complete, Boeh-
39) against the p55 TNF receptor extracellular domain were pro-
ringer Mannheim)). Cellular debris was removed by centrifugation,
duced in our laboratory (Engelmann et al., 1990a, 1990b). The rabbit
performed twice at 10,000 3 g for 5 min. The cell lysates were
polyclonal anti-total IkBa, anti-total c-Jun, anti-phospho c-Jun
precleared with 50 ml protein A-Sepharose beads and then incu-
(Ser63), anti-phospho c-Jun (Ser73), and anti-phospho JNK1/2/3
bated for 2 hr at 48C with 2 mg anti-p55 TNF receptor polyclonal
(Thr183/Tyr185) antibodies were purchased from New England Biolabs
antibodies, 8 mg anti-p55 TNF receptor mAb 34 plus mAb 39 (1:1),
(Beverly, MA). Recombinant human TNF was a gift from Dr. G. Adolf,
or 2 mg anti-NEMO polyclonal antibodies, then mixed with 40 ml
Boehringer Institute, Vienna, Austria.
of a slurry of protein G-Sepharose (Pharmacia, 1:1 with PBS) and
incubated for another 2 hr. The Sepharose beads were washed
Expression Vectors twice with 1 ml lysis buffer, twice with 1 ml high-salt (1 M NaCl)
The cDNAs for human p55 TNF receptor, RIP, TRAF2, NEMO, A20, lysis buffer, and twice more with the regular lysis buffer. Aliquots
and NIK were cloned into the pcDNA3 vector (Invitrogen, Carlsbad, corresponding to one-fourth of each sample were fractionated on
CA) with or without an additional 59 sequence encoding the FLAG, 10% SDS-PAGE and transferred to a nitrocellulose membrane and
HA, or His epitope. The expression vector for the antisense of NEMO probed with the indicated Abs. The antibodies were visualized with
was kindly provided by Drs. David Rothwarf and Michael Karin (San horseradish peroxidase±coupled sheep anti-mouse or anti-rabbit
Diego, CA), for the catalytic domain of MEKK1 (residues 360±672) immunoglobulin, using the enhanced chemiluminescence (ECL)
by Drs. Michael Kracht and Helmut Holtmann (Hannover, Germany), Western blotting detection system (Amersham, Little Chalfont, UK),
and for SEK1(K129R) by Dr. Rony Seger (Rehovot, Israel). The according to the manufacturer's instructions.
N-terminal deletion mutant of RIP (559±671) expression plasmid was For coimmunoprecipitation of transfected proteins, HEK 293T
generated by PCR. cells (2 3 106) were plated on 10 cm dishes and on the following
day were transfected by the calcium phosphate precipitation
method with the indicated expression plasmids, keeping the totalYeast Two-Hybrid Screening
The cDNA corresponding to the complete ORF of human RIP was amount of DNA constant (10 mg/dish) by supplementation with
pcDNA3 vector. After 24 hr the cells were rinsed once with PBS andcloned into the GAL4 DNA-binding domain vector pGBT9 (Clontech,
Palo Alto, CA). The resulting plasmid pGBT9-RIP was used as bait lysed in 1 ml lysis buffer (50 mM HEPES-NaOH [pH 7.6], 250 mM
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NaCl, 0.1% NP-40, 5 mM EDTA). Lysates were incubated with 1 mg ªdeath domainsº of the p55 tumor necrosis factor (TNF) receptor
and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects. J.anti-FLAG, anti-His, or control mouse IgG at 48C for 2 hr. The lysates
were mixed with 25 ml of a 1:1 slurry of protein G-Sepharose and Biol. Chem. 270, 387±391.
incubated for 2 hr. The Sepharose beads were washed with lysis Cao, Z., Henzel, W.J., and Gao, X. (1996). IRAK: a kinase associated
buffer and then subjected to 10% SDS-PAGE and Western analysis with the interleukin-1 receptor. Science 271, 1128±1131.
as described above. Chen, Z.J., Parent, L., and Maniatis, T. (1996). Site-specific phos-
To examine the effect of the RIP DD and of the antisense of NEMO phorylation of IkappaBalpha by a novel ubiquitination- dependent
on the recruitment of IKK1 to the p55 TNF receptor, HeLa HtTA-1 protein kinase activity. Cell 84, 853±862.
cells were plated on 15 cm dishes (5 3 106/plate) and transfected
Cohen, L., Henzel, W.J., and Baeuerle, P.A. (1998). IKAP is a scaffoldby the calcium phosphate precipitation method with a total of 30
protein of the IkappaB kinase complex. Nature 395, 292±296.mg DNA containing the appropriate expression plasmids. After 24
De Valck, D., Jin, D.Y., Heyninck, K., Van de Craen, M., Contreras,hr, cells were stimulated with TNF (100 ng/ml) for 10 min or left
R., Fiers, W., Jeang, K.T., and Beyaert, R. (1999). The zinc fingeruntreated. They were then pooled in batches of two plates (z107
protein A20 interacts with a novel anti-apoptotic protein which iscells) and lysed in 1 ml lysis buffer. Immunoprecipitations were
cleaved by specific caspases. Oncogene 18, 4182±4190.performed as described above, using 2 mg anti-p55 TNF receptor
polyclonal antibodies. Delhase, M., Hayakawa, M., Chen, Y., and Karin, M. (1999). Positive
To examine the association of A20 with the p55 TNF receptor and negative regulation of IkappaB kinase activity through IKKbeta
complex and its effect on the recruitment of IKK1 to the receptor subunit phosphorylation. Science 284, 309±313.
and to examine the effect of NEMO on IKK1 recruitment, HEK 293T DiDonato, J.A., Hayakawa, M., Rothwarf, D.M., Zandi, E., and Karin,
cells were seeded on 10 cm plates (2 3 106/plate). On the following M. (1997). A cytokine-responsive IkappaB kinase that activates the
day they were transfected by the calcium phosphate precipitation transcription factor NF-kappaB. Nature 388, 548±554.
method with the indicated expression plasmids, applying a total of
Engelmann, H., Novick, D., and Wallach, D. (1990a). Two tumor25 mg DNA/plate. After 24 hr, cells were pooled in batches of five
necrosis factor binding proteins purified from human urine. Evidenceplates (z107 cells) and lysed in 1 ml lysis buffer. Immunoprecipita-
for immunological cross reactivity with cell surface tumor-necrosis-tions were performed as described above for the coimmunoprecipi-
factor receptors. J. Biol. Chem. 265, 1531±1536.tation of endogenous proteins, using 2 mg anti-p55 TNF receptor
Engelmann, H., Holtmann, H., Brakebusch, C., Shemer Avni, Y.,polyclonal antibodies. In all cases presented, immunoprecipitation
Sarov, I., Nophar, Y., Hadas, E., Leitner, O., and Wallach, D. (1990b).was performed at least thrice, with qualitatively identical results.
Antibodies to a soluble form of a tumor necrosis factor receptor
have TNF-like activity. J. Biol. Chem. 265, 14497±14504.In Vitro Kinase Assays
Fields, S., and Song, O. (1989). A novel genetic system to detectHeLa S3 cells (5 3 107/sample) were stimulated with TNF (20 ng/
protein-protein interactions. Nature 340, 245±246.ml) for 10 min or left untreated. Cell lysates were subjected to immu-
noprecipitation with 2 mg anti-p55 TNF receptor or 1 mg anti-NEMO Ghosh, S., May, M.J., and Kopp, E.B. (1998). NF-kappa B and Rel
polyclonal antibodies, as described above. The immunoprecipitates proteins: evolutionarily conserved mediators of immune responses.
were further washed twice with 1 ml kinase buffer (20 mM HEPES- Annu. Rev. Immunol. 16, 225±260.
NaOH [pH 7.6], 2 mM DTT, 20 mM MgCl2, 20 mM MnCl2, 1 mM EDTA, Gossen, M., and Bujard, H. (1992). Tight control of gene expression
1 mM NaF, 20 mM b-glycerophosphate, and 0.1 mM Na3VO4). In in mammalian cells by tetracycline-responsive promoters. Proc.
vitro kinase reaction was allowed to proceed at 308C for 45 min in Natl. Acad. Sci. USA 89, 5547±5551.
20 ml kinase buffer supplemented with 10 mCi [g-32P]ATP and 1 mg
Heyninck, K., De Valck, D., Vanden Berghe, W., Van Criekinge, W.,bacterially expressed GST-IkBa (1±54). The reaction was stopped
Contreras, R., Fiers, W., Haegeman, G., and Beyaert, R. (1999). Thewith 20 ml SDS sample buffer, boiled for 5 min, fractionated on 10%
zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependentSDS-PAGE, and visualized by autoradiography.
gene expression by interfering with an RIP- or TRAF2-mediatedTo examine the effect of A20 on IKK kinase activity, HeLa HtTA-1
transactivation signal and directly binds to a novel NF-kappaB-cells were plated on 15 cm dishes (5 3 106/dish) and transfected
inhibiting protein ABIN. J. Cell Biol. 145, 1471±1482.with the appropriate expression plasmids (a total of 30 mg DNA/
Hsu, H., Huang, J., Shu, H.B., Baichwal, V., and Goeddel, D.V.dish) by the calcium phosphate precipitation method. After 24 hr,
(1996a). TNF-dependent recruitment of the protein kinase RIP tocells were stimulated with TNF (20 ng/ml) for 10 min. Dishes were
the TNF receptor-1 signaling complex. Immunity 4, 387±396.paired and their cells (z107) lysed in 1 ml lysis buffer. Immunoprecipi-
tations were performed using 1 mg anti-NEMO polyclonal antibody, Hsu, H., Shu, H.B., Pan, M.G., and Goeddel, D.V. (1996b). TRADD-
and the kinase assay was performed as described above. TRAF2 and TRADD-FADD interactions define two distinct TNF re-
ceptor 1 signal transduction pathways. Cell 84, 299±308.
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